Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

Metacrine, Inc. (MTCR) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/24/2023 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
03/24/2023 4 Klassen Preston (Director) has filed a Form 4 on Metacrine, Inc.
Txns: Granted 842,211 shares @ $0.47, valued at $395.8k
Disposed/sold 842,211 options to buy @ $0.47, valued at $395.8k
03/23/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/23/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/23/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/15/2023 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
03/08/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/03/2023 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
02/14/2023 SC 13G/A TANG CAPITAL PARTNERS LP reports a 10% stake in Metacrine, Inc.
02/13/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
02/09/2023 8-K Entry into a Material Definitive Agreement, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
02/08/2023 SC 13G/A BML Investment Partners, L.P. reports a 15.9% stake in Metacrine, Inc.
02/03/2023 8-K Quarterly results
02/01/2023 8-K Quarterly results
01/27/2023 4 York Michael (Chief Business Officer) has filed a Form 4 on Metacrine, Inc.
Txns: Sold 107,054 shares @ $0.4141, valued at $44.3k
01/27/2023 4 Klassen Preston (President & CEO) has filed a Form 4 on Metacrine, Inc.
Txns: Sold 380,605 shares @ $0.4132, valued at $157.3k
01/24/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
01/24/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Plan of Dissolution of Metacrine, Inc",
"Separation Agreement and General Release of All Claims, by and between Metacrine, Inc. and Preston Klassen"
12/21/2022 4 Leonard Braden Michael (10% Owner) has filed a Form 4 on Metacrine, Inc.
Txns: Bought 101,384 shares @ $0.4, valued at $40.6k
Bought 50,122 shares @ $0.3791, valued at $19k
Bought 120,099 shares @ $0.4, valued at $48k
12/19/2022 SC 13G TANG CAPITAL PARTNERS LP reports a 7.1% stake in Metacrine, Inc.
12/14/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
12/08/2022 SC 13D BML Investment Partners, L.P. reports a 15.2% stake in Metacrine, Inc.
10/26/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/26/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
10/11/2022 8-K Other Events  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
09/28/2022 425 Form 425 - Prospectuses and communications, business combinations:
09/27/2022 425 Form 425 - Prospectuses and communications, business combinations:
09/26/2022 425 Form 425 - Prospectuses and communications, business combinations:
09/07/2022 425 Form 425 - Prospectuses and communications, business combinations:
09/06/2022 4 Nashat Amir (10% Owner) has filed a Form 4 on Metacrine, Inc.
Txns: Granted 16,500 options to buy @ $0.42, valued at $6.9k
09/06/2022 4 JONKER JEFFREY DAVID (Director) has filed a Form 4 on Metacrine, Inc.
Txns: Granted 16,500 options to buy @ $0.42, valued at $6.9k
09/06/2022 4 McHutchison John G (Director) has filed a Form 4 on Metacrine, Inc.
Txns: Granted 16,500 options to buy @ $0.42, valued at $6.9k
09/06/2022 4 Owens Julia C. (Director) has filed a Form 4 on Metacrine, Inc.
Txns: Granted 16,500 options to buy @ $0.42, valued at $6.9k
09/06/2022 4 Heyman Richard A. (Director) has filed a Form 4 on Metacrine, Inc.
Txns: Granted 16,500 options to buy @ $0.42, valued at $6.9k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy